The PDGF-CC ligand was discovered towards the end of the 1990s and it has been shown to be involved in tumour growth by paracrine signalling through PDGFRα in malignant melanoma and cervical carcinoma [11, 12]. The gene discussed is PDGFRA; the disease is neoplasm.